Peak Flemish New Crown Prevention and Control Notes
Release time:
2020-07-15
The Chinese New Year holiday in 2020 was put at risk by the new coronavirus pneumonia. Before, although I heard that someone in Wuhan had pneumonia, I always felt that there was no need to worry about it thousands of miles away. On January 20, the "human-to-human" broke out, and on the morning of January 23, the news of Wuhan's city closure came. It was really a surprise.
It should be said that the group leaders are quite keen on epidemic prevention and control. On January 21, the group company issued two consecutive notices to remind employees not to go to Wuhan without special circumstances and to wear masks to prevent infection. Reduce visits to relatives and friends and avoid going to crowded places. Employees who have recently been to Wuhan and surrounding areas should avoid going out within 14 days after returning home. If they have symptoms of cold and fever, they should go to the hospital for examination in time and take the initiative to explain the situation... and so on. These tips have clear guiding significance for us who are ignorant. At that time, we, who had made various plans for the New Year, canceled the party one after another and hurried to buy masks and disinfectant to take personal protection.
Even so, the severity of the epidemic prevention and control situation is unimaginable-from 0:00 on January 24, Tianjin launched a first-level response to a major public health emergency. The last time was SARS in 2003. That's when we really realized the seriousness of the new coronavirus. At a loss, the group company issued the "Notice on Preventing New Coronavirus Pneumonia (No. 2)" on January 27, which made detailed and comprehensive arrangements for the organization of epidemic prevention and control, preparation of epidemic prevention supplies, daily epidemic prevention measures and implementation. This undoubtedly points out the focus and direction of the epidemic prevention and control work for us.
After receiving the notice, our Flemish company immediately set up an epidemic prevention leading group headed by General Manager Wang Wei, with a detailed division of labor and clear responsibilities. According to the division of labor, I am mainly responsible for the procurement of epidemic prevention supplies. After confirming the number of alcohol and masks available in the company with my colleagues, I called the supplier on the third day of the new year and asked him to leave us all the alcohol and masks on hand, and continue to add orders with the upstream to ensure our long-term epidemic prevention and resumption of production. Because the mercury thermometer is not convenient to use in the unit, I placed an appointment order for a thermometer in Alibaba for the first time. I was afraid of not being insured. I ran three pharmacies in a row, and finally found a thermometer. The price was ridiculously expensive. At the same time, Mr. Wang also contacted friends in the medical field to buy masks and other epidemic prevention materials. I heard that he could buy a thermometer gun, so I safely withdrew the online order. In order to facilitate the spraying of disinfectant in the office area, I went to the supermarket and bought two large watering cans. I have finished everything I can think of, and my nervous and anxious mood has finally settled down a little.
received the notice of the group to extend the holiday. on the one hand, Mr. Wang asked all employees to minimize going out and do a good job in home protection. on the other hand, he arranged me to set up a file from now on to record the temperature of each employee and co-residents, as well as the time and place of return of employees from other places, and to record the detailed travel situation of each employee in the past 14 days from January 31, actively prepare for the prevention and control of the epidemic and the safe resumption of work.
With the passage of time, the development of the epidemic is becoming more and more thrilling. Looking at the rising numbers every day, everyone's heart is full of panic. More and more people in the WeChat working group of the development zone are eagerly asking where to buy masks and where to find disinfectant. Through communication with the supplier, I learned that their additional 2 tons of alcohol had arrived and 20000 medical masks had been delivered, but they could not be received in time due to traffic barriers. I reported this situation to Mr. Wang again. Mr. Wang said that he had found 1000 masks over there, so that there would be enough time to wait for the masks behind the supplier. After straightening out the protective materials, I couldn't help but break out in a cold sweat. If it weren't for the foresight of the group leaders and the advance notice, they immediately put forward specific requirements for us to prepare epidemic prevention materials. I'm afraid I'm like other people. Like ants on a hot pot, I 've hit a wall everywhere without getting anything.
In order to facilitate the communication of epidemic prevention and control information, the Group and pharmaceutical companies have set up epidemic prevention and control groups, on the one hand, to pay attention to and guide the company's epidemic prevention and control work, requiring enterprises and each employee to sign a commitment to epidemic prevention and control, and effectively put epidemic prevention work in place. On the one hand, all employees of the group are required to learn the "Operation Manual for Resuming Trainees", so that every employee is aware of the various work requirements of returning to work and is prepared to fight. While stepping up efforts to educate employees, the Group and pharmaceutical companies have also introduced new coronary pneumonia emergency plans to guide companies around the world to prepare for the resumption of work. At present, the Group has a number of companies have been approved to resume work, we Flanders has also asked employees to learn and master the requirements of the resumption of work, and developed an epidemic prevention and control plan, to the Binhai New Area Development Zone submitted an application for resumption of work. "There are thousands of sails on the side of the sunken boat, and thousands of trees in front of the sick tree." I hope that our application for resumption of work can be approved as soon as possible, and that the Qingfei Liyan products developed in cooperation with medical institutions can be delivered to the hands of doctors and patients as soon as possible, so as to make our contribution to the prevention and control of the epidemic to the maximum extent. (Liu Hairong)
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31